0001255627-20-000002.txt : 20200910
0001255627-20-000002.hdr.sgml : 20200910
20200910173549
ACCESSION NUMBER: 0001255627-20-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200908
FILED AS OF DATE: 20200910
DATE AS OF CHANGE: 20200910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHREIBER DAVID
CENTRAL INDEX KEY: 0001255627
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34810
FILM NUMBER: 201169397
MAIL ADDRESS:
STREET 1: 15 TROTTERS LANE
CITY: MONROE
STATE: CT
ZIP: 06468
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aspira Women's Health Inc.
CENTRAL INDEX KEY: 0000926617
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 330595156
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12117 BEE CAVES ROAD BUILDING THREE
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78738
BUSINESS PHONE: 512-519-0400
MAIL ADDRESS:
STREET 1: 12117 BEE CAVES ROAD BUILDING THREE
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78738
FORMER COMPANY:
FORMER CONFORMED NAME: VERMILLION, INC.
DATE OF NAME CHANGE: 20070824
FORMER COMPANY:
FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC
DATE OF NAME CHANGE: 20000316
FORMER COMPANY:
FORMER CONFORMED NAME: ABIOTIC SYSTEMS
DATE OF NAME CHANGE: 19950407
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2020-09-08
0
0000926617
Aspira Women's Health Inc.
AWH
0001255627
SCHREIBER DAVID
C/O ASPIRA WOMEN'S HEALTH INC.
12117 BEE CAVES RD BLDG 3 STE 100
AUSTIN
TX
78738
1
0
0
0
Common Stock
2020-09-08
4
S
0
50000
2.78
D
185018
D
The proceeds are intended to cover tax liability for restricted stock units of Aspira Women's Health Inc. received in 2020.
The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.75 to $2.85 per share. The reporting person undertakes to provide to Aspira Women's Health Inc., any security holder of Aspira Women's Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
/s/ David Schreiber
2020-09-10